SSB
ARCT icon

Sandy Spring Bank’s Arcturus Therapeutics ARCT Stock Holding History

Sandy Spring Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$1.7K – 1229
2024
Q4 		$1.7K Buy
100
+75
+300% +$1.41K ﹤0.01% 1077
2024
Q3 		$581 Buy
+25
New +$535 ﹤0.01% 1115

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sandy Spring Bank's ARCT Position: Q1 2025 in Review

Sandy Spring Bank sold out of Arcturus Therapeutics (ARCT) in Q1 2025, closing a stake of 100 shares — an estimated $1.7K sold.

Sandy Spring Bank first reported a position in ARCT in Q3 2024 and held it in 2 quarters. The position peaked at $1.7K in Q4 2024. 144 funds tracked by Wall St. Rank hold ARCT as of Q1 2025.

  • Sandy Spring Bank reported no remaining Arcturus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Sandy Spring Bank sold 100 Arcturus Therapeutics shares in Q1 2025, an estimated $1.7K.
  • Sandy Spring Bank first reported a position in Arcturus Therapeutics in Q3 2024 and held it in 2 quarters.
  • Sandy Spring Bank's Arcturus Therapeutics position peaked at $1.7K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.